Review
Open access
Aug 2026
Novel Lipoprotein (a) Therapies: A Comprehensive Review
The Lp(a) treatment landscape has moved from basic science to an active late-stage clinical pipeline and positive outcomes from these CVOTs could lead to regulatory approvals and guideline updates affecting hundreds of millions of high-risk patients globally.
U. Ebubechukwu, O. Ugoala, Rameen Shahid et al.
· Current Atherosclerosis Repo... · 0 citations